Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Ciclopirox Olamine

    • Product Name Ciclopirox Olamine
    • Alias CPO
    • Einecs 259-627-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    526221

    generic_name Ciclopirox Olamine
    chemical_class Hydroxypyridone antifungal
    dosage_form Cream
    common_concentration 1%
    route_of_administration Topical
    indications Fungal skin infections
    mechanism_of_action Disrupts fungal cell membrane synthesis
    prescription_status Prescription only
    storage_temperature Below 25°C
    color White to off-white

    As an accredited Ciclopirox Olamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Ciclopirox Olamine features a 100-gram white HDPE bottle with a secure screw cap and clear labeling.
    Shipping Ciclopirox Olamine should be shipped in tightly sealed containers, protected from light and moisture. It must be packed according to local and international regulations for chemical transport. Store and transport at room temperature, avoiding excessive heat and humidity. Ensure appropriate labeling and documentation for safe handling and delivery.
    Storage Ciclopirox Olamine should be stored at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). Keep the container tightly closed and protected from light and moisture. Store in a cool, dry place away from incompatible substances and out of reach of children. Avoid freezing and ensure the storage area is well-ventilated, following all safety guidelines.
    Application of Ciclopirox Olamine

    Applications of Ciclopirox Olamine in Industrial Manufacturing

    Ciclopirox Olamine serves a critical function as a key active ingredient in various personal care and pharmaceutical manufacturing environments. Its specific antifungal properties have established its use in a defined set of regulated downstream formulations. Below we outline thoroughly validated industrial applications, including sector standards, recommended usage ratios, integration methods, and finished product classes.

    1. Topical Antifungal Formulations for Dermatology

    Pharmaceutical manufacturers rely on this raw material as the principal antifungal agent in the preparation of medicinal skin creams, gels, and lotions to treat dermatomycoses such as tinea corporis, tinea cruris, and cutaneous candidiasis. Quality assurance teams evaluate each batch to ensure that the ingredient meets strict monograph specifications through in-process and final release testing, addressing the compliance demands associated with topical drug production for global distribution.

    Industry compliance standards

    • United States Pharmacopeia (USP) Monograph for Ciclopirox Olamine
    • European Pharmacopoeia (Ph. Eur.) standards
    • Current Good Manufacturing Practice (cGMP), 21 CFR Parts 210 & 211
    • ICH Q6A Specifications: Test Procedures and Acceptance Criteria

    Typical usage ratio

    • 1% (w/w) for general topical creams and lotions; some regional monographs specify a range between 0.77% – 1.0% according to disease severity and regulatory submission. Adjustment depends on formulation type and intended market registration.

    Downstream process integration

    • Added into the aqueous or oil phase during the compounding step of emulsion-based creams or gels. Homogenization at controlled temperature (25-35°C) ensures uniform dispersion prior to packaging.

    Final product types

    • OTC and prescription antifungal creams (hydrophilic and lipophilic bases)
    • Dermatological gels for tinea and cutaneous yeast infections
    • Medicated lotions applied for scalp and large skin areas

    2. Anti-Dandruff Shampoos and Hair Care Lotions

    Formulators in the personal care sector incorporate this active to inhibit Malassezia species associated with dandruff and seborrheic dermatitis. Compliance with cosmetic and medicated shampoo legislation guides technical teams during process qualification, especially for high-volume production lines targeting a consumer base with recurring scalp hygiene issues.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • US FDA Over-the-Counter (OTC) Monograph for Dandruff Treatments, 21 CFR Part 358
    • China National Medical Products Administration (NMPA) Technical Standards
    • ISO 22716:2007 Cosmetics — Good Manufacturing Practices (GMP)

    Typical usage ratio

    • 1.5% (w/w) as the finished product maximum for shampoos, per EU Cosmetic Ingredient Database (CosIng) and country registration guidelines. Some regions permit 0.77% – 1.5% depending on anti-dandruff claim and hair lotion format.

    Downstream process integration

    • Incorporated during the surfactant blending stage, usually after water phase preparation. To ensure bioactivity, it is stabilized with pH adjusters and compatible preservatives before bottling operations.

    Final product types

    • Anti-dandruff shampoos (mass market and prescription)
    • Leave-on and rinse-off scalp lotions
    • Combined anti-fungal and keratolytic conditioner products

    3. Antifungal Nail Lacquers and Onychomycosis Solutions

    Specialty pharmaceuticals deploy Ciclopirox Olamine as the active film-former in nail lacquer systems used to manage and treat onychomycosis. Quality control teams verify conformity with pharmacopoeia for both the raw material and the solvent-polymer lacquer matrix. The design of these solutions requires careful consideration of permeation parameters and regulatory dossier support for treatment of fungal nail infections.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur.) Nail Lacquer Monograph
    • FDA NDA and Abbreviated New Drug Application (ANDA) Guidance for Topical Antifungals
    • EMA Guideline on Quality of Transdermal Patches and Topical Products
    • PIC/S Guide to Good Manufacturing Practice for Medicinal Products

    Typical usage ratio

    • 8% (w/w) as the standard concentration in nail lacquers to achieve required therapeutic action per EU-approved products; minor formulation adjustments made for viscosity and film-forming capacity.

    Downstream process integration

    • Dissolved directly into solvent-based lacquer solutions during mixing, prior to addition of cosmetic plasticizers. Cross-check performed for uniformity and stability before final sterilization and bottling.

    Final product types

    • Medicated nail lacquers for onychomycosis (prescription-only)
    • Single-use antifungal nail paints for institutional clinics
    • Adjunctive antifungal treatment kits for podiatry markets

    4. Veterinary Dermatological Formulations

    Industrial veterinary pharmaceuticals utilize Ciclopirox Olamine for the treatment and prevention of superficial fungal infections in companion animals, especially where skin sensitivity prohibits harsher actives like azole-based compounds. Raw material sourcing and formulation are subject to stringent animal safety regulations and require close batch traceability.

    Industry compliance standards

    • VICH GL43 Stability Testing for New Veterinary Drug Products
    • European Medicines Agency (EMA) CVMP Guidelines for Topical Veterinary Products
    • FDA Center for Veterinary Medicine (CVM) Guidance for Industry 185
    • Good Manufacturing Practices for Veterinary Preparations (EU GMP Vol 4, Annex 1 & 5)

    Typical usage ratio

    • 1% (w/w) for animal skin creams and sprays targeting dermatophytosis. Lower application rates (0.5% – 1%) used for maintenance preventive products according to veterinary formulation reviews.

    Downstream process integration

    • Added during the cooling phase of emulsification following the main oil and water phase mixing, ensuring stability with common veterinary excipients before filling in precision metered dispensers.

    Final product types

    • Topical antifungal creams for dogs and cats
    • Antifungal veterinary sprays for pets and small livestock
    • Animal-use antifungal barrier ointments
    Free Quote

    Competitive Ciclopirox Olamine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Ciclopirox Olamine: A Manufacturer’s Perspective

    Real Production Experience Behind Ciclopirox Olamine

    Ciclopirox Olamine stands out among topical antifungal agents, not only from a pharmaceutical perspective but also in our day-to-day manufacturing process. Over the years, we have refined our techniques to yield a material that balances stability, purity, and process efficiency. With its molecular formula C14H24N2O3, Ciclopirox Olamine is represented by a fine white to slightly off-white powder, a result immediately visible by the time each batch leaves our final filtration and drying columns. Every kilogram produced reflects careful control of operating parameters, whether we’re managing reaction times during the salt formation or monitoring trace content in the final crystallization.

    In our work, process control has made a real difference in the quality that reaches the pharmaceutical market. Water content in this product is not just a technicality; even small shifts in this parameter affect downstream stability and application qualities. We invest in Karl Fischer titration throughout production, not simply for numbers on a datasheet, but to give our partners material that handles reliably. Impurities such as unreacted ciclopirox, residual solvents, or amines, threaten both shelf life and regulatory compliance. Our purification protocol does not rely solely on a single crystallization step; multi-stage washes and careful pH adjustment protect the integrity of the olamine.

    Specification Experience: From Process to Product

    In the manufacturing environment, we see up close how specifications written in the lab translate from small glassware to robust industrial batches. Typical batch size ranges from twenty to several hundred kilograms, and each has its own fingerprint. The assay, measured as a percentage of Ciclopirox Olamine by HPLC, consistently falls within 98.0% to 102.0%. This isn’t just a number: out-of-spec results force rework, delay shipments, and ultimately signal inefficiency or process slip.

    Visual cues mean something as well. A pure, odorless, white powder indicates well-controlled processing and filtration; off-color or odors tell us that solvents or intermediates have not been adequately removed. Particle size distribution, though not often specified officially, impacts the ease of blending into creams or lotions. We run periodic sieve analyses and pay attention to flow characteristics — not for show, but to make sure formulators do not encounter lumps or poor dispersion. Moisture control translates directly into user experience, especially with hydrophilic excipients or high-humidity environments.

    Why This Active is Favored in Topical Formulations

    Having worked with many active ingredients over the years, we understand why Ciclopirox Olamine remains a preferred choice. Its broad-spectrum antifungal activity covers dermatophytes, yeasts, molds, and some bacteria, useful for treating a range of skin infections. Unlike imidazoles or other azoles, it does not depend on ergosterol inhibition alone but interrupts cellular metabolism and membrane transfer processes, reducing the likelihood of resistant strains emerging.

    We regularly field questions from downstream partners about batch-to-batch reproducibility. A consistent product not only helps avoid regulatory issues but also builds trust during scale-up. We apply real-time monitoring tools — not only laboratory QC but also inline FTIR and temperature mapping during critical steps — to ensure active content meets specification and corrosion-sensitive process lines are protected.

    Real Differences Compared to Similar Products

    Manufacturing teams see, in practical terms, why a material like Ciclopirox Olamine is not interchangeable with other topical antifungals. Many customers enquire whether clotrimazole or ketoconazole, for example, offer a comparable substitute. From a chemical perspective, these molecules differ in solubility, mechanisms, and even odor and appearance.

    Ciclopirox Olamine dissolves quickly in water and alcohol—a benefit for formulators crafting both oil-in-water and water-in-oil topical vehicles. Other actives often come as less soluble powders or oils, requiring surfactants or even special solubilizers, adding complexity to emulsion stability. Ciclopirox Olamine achieves strong antibiofilm action, which we validate during every run by monitoring purity and microbiological activity in retained samples.

    If the olamine form matters, end-use tells us why: while the base (Ciclopirox) offers similar antifungal effect, Olamine brings higher solubility and better skin compatibility. Pharmacists and pharmaceutical formulators care about this, since it impacts everything from product labeling to user comfort over multi-week regimens.

    Our Ongoing Focus: Transparency, Traceability, and Stewardship

    Our production site adheres to cGMP standards, a necessity rather than a formality. All sources of raw materials, from pyridone starting material to bulk solvents, are documented for traceability. On occasion, changes in supplier quality can force adjustments in reaction timing, filter media, or solvent recovery. Rather than hiding these challenges, our technical team communicates openly with our partners about anticipated impacts on process or finished material.

    Providing clear documentation runs deeper than preparing COAs. During regulatory audits, we open our process records and share deviations, reworks, and corrective actions. We see a direct link between transparency and long-term business relationships. If a batch drifts close to impurity tolerances, we increase sampling frequency and, if warranted, reprocess or downgrade affected material. This approach protects our downstream partners and end users.

    Responsible Production: Commitment to Quality and Environment

    Responsible chemical production means more than just checking boxes. Our site reduces solvent waste through closed-loop distillation, using off-gases as fuel in onsite steam generators. Filtration residue doesn’t simply go to landfill; we work with certified hazardous waste partners for safe material recycling when possible. Efforts to minimize water and solvent use have led to a twenty percent reduction in process waste over the past three years—a fact visible in our annual disclosures and reflected in local permit renewals.

    Each new regulatory filing or customer audit pushes us to keep improving. We have adopted more stringent internal guidelines than some local markets demand, from lowering residual solvent thresholds to running batch printouts through an independent review before release. None of these efforts slow us down; in fact, our process yields and customer satisfaction rates are higher for it.

    Meeting Formulator Demands: Hands-On Solutions and Ongoing Support

    Our technical team supports formulators beyond the point of shipment. We routinely answer questions about incorporating Ciclopirox Olamine into creams, gels, or nail lacquers. Experience tells us that excipient compatibility demands more than just literature review; we run small-scale pilot blends upon request, sharing detailed dispersion, color, and pH stability data. Product recalls can devastate business relationships and reputations, so we invest in batch archiving, keeping samples for repeat analysis even long after the lot has shipped.

    Some formulators run into issues with pH drift during storage or undesired color changes. Our feedback loop helps identify which stabilizers or co-solvents cause problems with the antifungal, greatly reducing troubleshooting time. By listening to end users and pharmacists, we stay aware of trends in vehicle composition — whether for water-based gels, hydroalcoholic solutions, or newer delivery forms.

    Regulatory Experience: Staying Ahead in a Changing Landscape

    Navigating regulatory requirements has become a core part of our business, guided by years of cumulative expertise. English and regional pharmacopoeias regularly update impurity profiles or residue guidelines, and staying compliant involves not just altering process parameters but also updating validation protocols. Visits from international quality auditors prompt regular retraining, and we invest in in-house QA labs with both HPLC and new UPLC equipment.

    New monographs challenge our team to re-examine every cleaning, transfer, and storage procedure. Meeting these standards can mean tighter controls on temperature, shorter material hold times, or changes in packaging to prevent moisture ingress. These are not empty compliance exercises — we see the difference physically in longer shelf life and fewer customer complaints.

    Innovation: Process Improvements from the Plant Floor

    For a mature active ingredient like Ciclopirox Olamine, innovation means process improvement. Over the past decade, we have implemented feedback from both plant operators and R&D chemists, who see the reaction vessel pressures, reflux column condition, or drying times long before the QC chemists sign off. Along the way, we switched from batch to semi-continuous modes on critical steps, getting tighter control of temperature profiles and reducing cycle variance. Automation hasn’t replaced hands-on craftsmanship, but it has allowed our skilled operators to spot batches that veer off the ideal temperature window or develop off-odors quickly.

    Environmental monitoring—particulate checks, humidity mapping, and microbiological counts—identifies hotspots for improvement. In recent years, we have updated our air handling systems and installed energy recovery ventilators to manage heat loads, thus improving working conditions inside the plant as well as product quality. Operators see the benefits, too, with better ergonomics, reduced handling of bulk bags, and fewer manual sampling errors.

    Feedback, Learning, and Customer Relationships

    Customer feedback shapes much of what we do, from process tweaks to special packaging requests. Global shipping often exposes product to wide temperature and humidity extremes, so we have adopted new drum lining materials and tested incoming product integrity under controlled shipping stress scenarios. Each issue reported, even rare discoloration or clumping, becomes a learning opportunity. We trace every affected batch through our quality system, investigate root causes, and communicate findings openly with both logistics partners and customers.

    A close working relationship with both downstream formulators and regulatory authorities means we sometimes co-develop new analytical methods. Stability studies using real-world storage – not just artificial accelerated aging – help customers plan accurate shelf lives and avoid unexpected losses in activity. Our post-market vigilance system collects data from users, feeding back into process tweaks that benefit all parties.

    Supporting Modern Healthcare Needs

    Ciclopirox Olamine offers a dependable option for clinicians tackling superficial fungal infections, particularly where other actives fail or meet user tolerance issues. We see growing demand for combination skin products that merge antifungal, antibacterial, and anti-inflammatory actions. The unique properties of this active – rapid onset, good penetration, and low irritation – make it an ally for manufacturers developing new formulations for difficult-to-treat areas, including nails and scalp.

    Doctors and pharmacists regularly ask about residue, absorption, and risk of resistance. By maintaining tight specifications, supplying detailed impurity profiles, and sharing up-to-date resistance data, we give healthcare professionals tools to use this product confidently. For special markets, including pediatric and geriatric care, we work with specialist partners to ensure that our ingredient meets added safety and tolerability standards.

    Understanding the Market: Adaptability to Regional Needs

    Markets across Europe, America, and Asia each have unique demands. European partners request low-residual solvents and robust impurity controls. In tropical countries, long supply chains mean controlling water and heat ingress is essential to keeping the product stable and effective on arrival. We adapt warehouse practices and shipment schedules to local climate, and we offer tailored packaging — sometimes double lining, sometimes using desiccant canisters, all documented upon shipment.

    Our experience with local manufacturing standards informs every global shipment. Whether working with well-established multinational drug makers or smaller compounding pharmacies, our team gives equal attention to validation, documentation, and after-sales support. Regional audits have made us acutely aware of special labeling, registration, or language requirements, which feed into our export department’s quality control checks.

    Continuous Improvement: Training, Technology, and Collaboration

    Training is an ongoing endeavor in our plant. Our operators know that process changes can shift quality, so every update in equipment or process triggers practical retraining. We encourage cross-training so team members from QA, production, and logistics can identify potential risks from different viewpoints and recommend improvements before deviations occur.

    We participate in cross-industry collaborations focused on improving process safety, energy efficiency, and product stewardship. Using new analytical technologies — like automated sample preparation or data-mining tools — we can spot subtle trends in impurity profiles or production yields long before they affect customer supply. Each incremental gain, no matter how modest, adds to our capacity for reliable, timely supply.

    A Manufacturer’s Commitment: Looking Forward

    Ciclopirox Olamine is much more than an antifungal ingredient: for us, it’s a daily exercise in combining chemistry, engineering, and partnership. Every batch reflects years of collective knowledge, careful attention to detail, and open communication with stakeholders all along the value chain. Ongoing investment in process robustness and transparency helps us continue meeting the market’s highest expectations.

    We stay alert to shifts in regulation, health demands, and global supply networks, and we keep learning from every production run, customer question, and laboratory test result. Long-term, our goal remains steady: deliver consistently high-quality Ciclopirox Olamine, produced responsibly, supporting both innovation and safety in modern healthcare solutions.